ESD expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.791200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.036800E-01
Normal-vs-Stage2
5.590800E-01
Normal-vs-Stage3
4.639400E-01
Normal-vs-Stage4
9.413400E-01
Stage1-vs-Stage2
6.452800E-01
Stage1-vs-Stage3
3.237000E-01
Stage1-vs-Stage4
5.997200E-01
Stage2-vs-Stage3
3.532800E-01
Stage2-vs-Stage4
4.315400E-01
Stage3-vs-Stage4
2.967000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.757600E-01
Normal-vs-AfricanAmerican
6.465400E-01
Normal-vs-Asian
4.941600E-01
Caucasian-vs-AfricanAmerican
9.736800E-01
Caucasian-vs-Asian
8.317800E-01
AfricanAmerican-vs-Asian
9.004400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.981200E-01
Normal-vs-Female
5.738600E-01
Male-vs-Female
9.819600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.904000E-01
Normal-vs-Age(41-60Yrs)
7.620000E-01
Normal-vs-Age(61-80Yrs)
4.892200E-01
Normal-vs-Age(81-100Yrs)
9.824400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.506800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.997800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.666800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
5.967600E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.296800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
1.618830E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.517400E-01
Normal-vs-Daily Drinker
2.666400E-01
Normal-vs-Weekly Drinker
5.246000E-01
Normal-vs-Occasional Drinker
9.874000E-01
Normal-vs-Social Drinker
7.239400E-01
Non Drinker-vs-Daily Drinker
8.685600E-01
Non Drinker-vs-Weekly Drinker
5.549600E-01
Non Drinker-vs-Occasional Drinker
5.060300E-02
Non Drinker-vs-Social Drinker
3.169000E-01
Daily Drinker-vs-Weekly Drinker
4.446400E-01
Daily Drinker-vs-Occasional Drinker
3.242400E-02
Daily Drinker-vs-Social Drinker
2.487800E-01
Weekly Drinker-vs-Occasional Drinker
2.340400E-01
Weekly Drinker-vs-Social Drinker
7.040000E-01
Occasional Drinker-vs-Social Drinker
4.694400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
8.109700E-02
Normal-vs-Grade 2
5.577900E-03
Normal-vs-Grade 3
1.825630E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.666250E-01
Grade 1-vs-Grade 3
4.580200E-01
Grade 1-vs-Grade 4
8.109700E-02
Grade 2-vs-Grade 3
5.458000E-01
Grade 2-vs-Grade 4
5.577900E-03
Grade 3-vs-Grade 4
1.825630E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.993000E-01
Normal-vs-NonDiabetic
5.726400E-01
Diabetic-vs-NonDiabetic
4.899000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.111200E-01
Normal-vs-NoPancreatitis
5.723800E-01
Pancreatitis-vs-NoPancreatitis
3.192600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.881400E-01
Normal-vs-N1
5.646800E-01
N0-vs-N1
4.822400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
9.274000E-01
Normal-vs-TP53-NonMutant
5.737400E-01
TP53-Mutant-vs-TP53-NonMutant
8.306000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
